Women are more likely to survive a stroke, but have worse disability and poorer quality of life afterwards compared to men, suggests research published recently in Neurology, the medical journal of the American Academy of Neurology.
In the study, George Institute for Global Health researchers looked at sex differences in treatment and outcomes in 19,652 individuals who had been part of five international randomized controlled trials to identify how to improve the lives of both men and women after a stroke.
Variations in how women were treated in hospital and whether they had been receiving appropriate treatment for their risk factors beforehand may partly explain the differences found in the study, lead author Dr Cheryl Carcel suggests, in a media release from George Institute for Global Health.
“While the trials we looked at did not specifically investigate treatments, we found a hint that while women who had a stroke were more likely to be admitted to an acute stroke unit, they were less likely to be intubated, treated for fever, or admitted to an intensive care unit compared to men. Admission to an acute stroke unit may play a role in the increased survival seen in women,” she says.
“There was also a hint that women were more likely to be taking blood pressure lowering medication, but less likely to have been prescribed blood thinning, glucose-lowering or lipid-lowering medication prior to their stroke than men. This is similar to other studies in cardiovascular disease, but we are planning to look at this more closely in further research.”
“While we know women tend to be older when they have a stroke and are more likely to have key risk factors such as high blood pressure and irregular heart rhythms than men, whether they are treated differently and how that affects their longer-term outlook was less certain,” she adds.
“It is clear that women and men require different types of support after stroke, but physicians may also need to pay more attention to risk factor control in women.”
Sex differences in disease risk, management, and outcome are an increasing focus of research and health services delivery, and the study confirmed stroke is an area that needs to be considered in this context, per the release.
“In the trials we considered for our analysis, there was an under-representation of women – just 37 percent women in one trial and 42 percent in another.”
“In order to ensure that treatment is beneficial for both sexes, we are advocating for the adequate representation of women in clinical trials – especially in drug trials – and for conducting sex disaggregated analysis of the results.”
“Women and men are similar in many ways but there is an undeniable abundance of evidence of sex and gender differences not only in stroke but also in many other diseases. Understanding the way sex and gender influence the manifestation of certain diseases, how healthcare is utilized and the response to medical treatment not only encourages equity, but also saves lives and money,” Carcel concludes.
[Source(s): George Institute for Global Health, EurekAlert]
